Chronic Obstructive Pulmonary Disease Copd clinical trials

Explore recruiting chronic obstructive pulmonary disease copd clinical trials.

Recruiting chronic obstructive pulmonary disease copd studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Chronic Obstructive Pulmonary Disease Copd trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 2b/Phase 3, randomized, double-blind, placebo-controlled, multicenter study, to investigate the efficacy and safety of lunsekimig in adult participants with inadequately controlled chronic obstructive pulmonary disease (COPD) characterized by an eosinophilic phenotype

Denmark, Sweden, Poland, Estonia, Portugal, Latvia +7 more

Phase II and Phase III (Integrated) EU CTIS Study details

A Phase 2b/Phase 3, randomized, double-blind, placebo-controlled, multicenter study, to investigate the efficacy and safety of lunsekimig in adult participants with inadequately controlled chronic obstructive pulmonary disease (COPD) characterized by an eosinophilic phenotype

Germany, Romania, Greece, Norway, Netherlands, Poland +4 more

Phase II and Phase III (Integrated) EU CTIS Study details

A Phase 2b Randomized, Double-blind, Placebo-controlled, Parallel-Group Study to Assess Efficacy and Safety of Verekitug (UPB-101) in Participants with Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)

Romania, Lithuania, Hungary, Spain, Bulgaria, Ireland +5 more

Therapeutic exploratory (Phase II) EU CTIS Study details

A Double Blind, Multicentre, Randomised Three-Period, Three-Treatment, Cross-Over Study To Evaluate The Effect of BGF MDI, BFF MDI and Placebo MDI on Exercise Parameters In Participants with Chronic Obstructive Pulmonary Disease (ATHLOS)

Germany, Spain

Phase III and phase IV (Integrated) EU CTIS Study details

A single group treatment, phase 4, study to assess the effect of 1 dose with oxymetazoline nasal spray(Otrivin®) on physical capacity of males and females aged 18 and 64 years suffering from Chronic Obstructive Pulmonary Disease (COPD)

Norway

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase III, Multicentre, Randomised, Double-blind, Chronic-dosing, Parallel-group, Placebo-controlled Extension Study to Evaluate the Long-term Efficacy and Safety of Tozorakimab in Participants with Chronic Obstructive Pulmonary Disease (COPD) with a History of Exacerbations (PROSPERO)

Sweden, Romania, Spain, Italy, Germany, Poland +11 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Chronic Obstructive Pulmonary Disease Copd trials by city

Chronic Obstructive Pulmonary Disease Copd in Toronto Chronic Obstructive Pulmonary Disease Copd in Vancouver Chronic Obstructive Pulmonary Disease Copd in Montreal Chronic Obstructive Pulmonary Disease Copd in Calgary Chronic Obstructive Pulmonary Disease Copd in Edmonton Chronic Obstructive Pulmonary Disease Copd in Ottawa Chronic Obstructive Pulmonary Disease Copd in Winnipeg Chronic Obstructive Pulmonary Disease Copd in Quebec City Chronic Obstructive Pulmonary Disease Copd in Hamilton Chronic Obstructive Pulmonary Disease Copd in Kitchener Chronic Obstructive Pulmonary Disease Copd in London Chronic Obstructive Pulmonary Disease Copd in Halifax Chronic Obstructive Pulmonary Disease Copd in New York Chronic Obstructive Pulmonary Disease Copd in Los Angeles Chronic Obstructive Pulmonary Disease Copd in Chicago Chronic Obstructive Pulmonary Disease Copd in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease